跳至主要内容
临床试验/DRKS00010148
DRKS00010148招募中不适用

A registry for hemophagocytic lymphohistiocytosis (HLH) - HLH registry

niversitätsklinikum FreiburgCentrum für Chronische Immundefizienz (CCI)0 个研究点目标入组 300 人开始时间: 2016年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • Patients with primary immunodeficiencies predisposing to HLH (all ages)
  • Patients fulfilling >/= 4/8 diagnostic criteria for HLH as defined by the Histiocyte Society and receiving HLH directed therapy (steroids are sufficient)
  • Patients presenting with a high suspicion of isolated CNS-HLH and receiving HLH directed therapy
  • Patients with active HLH that is not secondary to underlying conditions such as rheumatological disease, malignancy, metabolic disease or Leishmania infection (mostly infection-only” HLH) (all ages)
  • Patients (or their legal representatives) having provided informed consent

排除标准

  • Patients with malignancy
  • Patients with rheumatological/autoinflammatory/autoimmune disease
  • Patients with metabolic diseases
  • Patients with Leishmania infection
  • No written consent available

研究者

发起方
niversitätsklinikum FreiburgCentrum für Chronische Immundefizienz (CCI)

相似试验